Solid tumor
Conditions
Interventions
Proton beam therapy system
Sponsors
Department of Radiation Medicine, Hokkaido University Graduate School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients with pathologically proved malignant tumor, or pathologically proved benign disease that the effectiveness of X-ray treatment was verified 2) Patients with clinically evident malignant disease 3) Patients with clinically benign disease that the effectiveness of X-ray treatment was verified 4) A well-informed written consent was obtained from the patient (and the person with parental authority if the patient was younger than age 20 years) 5) PS is 0-3 in the criteria of ECOG
Exclusion criteria
Exclusion criteria: 1) with serious active infections in the irradiated sites 2) with severe diabetes that uncontrolled, or treated by using insulin 3) with severe heart disease, or some serious complications, i.e., SLE, Scleroderma, interstitial pneumonia 4) pregnant or likely to be 5) considered that participation in this trial is difficult because of psychiatric symptoms or psychosis 6) the proposed radiation treatment site had been given tolerance dose in the past 7) Patient who cannot be held rest for about 30 minutes, except the patient younger than 20 years old who can be held rest under sedation 8) weight over 135kg 9) unsuitable for enrollment judged by principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of the early phase adverse invent induced by radiotherapy using Proton beam therapy system | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) changes in tumor volume 2) changes in tumor marker 3) changes in subjective symptoms or QOL | — |
Countries
Japan
Contacts
Public ContactShinichi Shimizu
Hokkaido University Graduate School of Medicine Department of Radiation Oncology
Outcome results
None listed